hotspot -WSS

hotspot

author：Wikipedia 2025-10-02 20:49:55 - browse：55638

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine?

That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday. “Could we think about vaccine-like properties, where imagine you had, once a year, an injection with an equivalent of a GLP-1 that really helps you to maintain weight loss and have cardiovascular benefits?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： How Long Island became the ‘eugenics capital of the world’

entertainment

WSS

How to make Best Hospitals ratings actually useful for patients

Novo pauses ads for weight loss drug Wegovy amid demand

Patients, doctors are clashing about side effects of hormonal birth control

Australia’s approach to dialysis celebrates life

Study finds new variant for Parkinson’s in African populations

How to fix the rural physician shortage in the U.S.

hotspot

hotspot

hotspot

Apple is now the first public company to be valued at $3 trillion

FDA panel gives mixed vote on blood pressure devices

How to save PrEP access — and even expand it

As pharma fights Medicare drug negotiation, hospitals, docs silent

Peter Hotez and the public health issue of online harassment

Can medical device makers keep up in the race to treat obesity?

Tori Bowie and the unacceptable rates of Black maternal death

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Anesthesiologist group: stop taking Ozempic before surgery

Reanimated hearts work just as well for transplants, study finds

Wikipedia

Novo pauses ads for weight loss drug Wegovy amid demand

Eli Lilly’s Mounjaro succeeds in second weight

Mom launches Girl Scout troop for LGBTQ youth in Texas

Patients, doctors are clashing about side effects of hormonal birth control

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

What AAP's gender

hotspot

focus

entertainment

hotspot